Skip to main content
MIT Corporate Relations
MIT Corporate Relations
Search
×
Read
Watch
Attend
About
Connect
MIT Startup Exchange
Search
Sign-In
Register
Search
×
MIT ILP Home
Read
Faculty Features
Research
News
Watch
Attend
Conferences
Webinars
Learning Opportunities
About
Membership
Staff
For Faculty
Connect
Faculty/Researchers
Program Directors
MIT Startup Exchange
User Menu and Search
Search
Sign-In
Register
MIT ILP Home
Toggle menu
Search
Sign-in
Register
Read
Faculty Features
Research
News
Watch
Attend
Conferences
Webinars
Learning Opportunities
About
Membership
Staff
For Faculty
Connect
Faculty/Researchers
Program Directors
MIT Startup Exchange
4.4.23-Health-Gootenberg-Abudayyeh
Conference Video
|
Duration: 34:13
April 4, 2023
View this past event
Preview
4.4.23-Health-Gootenberg-Abudayyeh
Please
login
to view this video.
Video details
As we further understand the complexity and diversity of cellular states, it is becoming necessary for a cellular engineering toolbox, consisting of molecular tools that allow control over cell states and types. Drawing from a combination of natural discovery and rational engineering, we will discuss our lab's recent work in this area. We will cover RNA, DNA, and cell targeting approaches, including the novel CRISPR effector, Cas7-11, that can be used to target transcripts in mammalian cells for degradation, with reduced toxicity; a new genome insertion system, PASTE, that enables efficient, programmable insertion of large DNA segments into the genome without limitations of previous genome editing approaches; and a new approach for control of cell states, RADARS, that can sense and react to transcript levels in cells. These technologies form the basis or new approaches to manipulate and understand cellular states, with implications in basic biology, diagnostics, and therapeutics.
Locked Interactive transcript
Please
login
to view this video.
Video details
As we further understand the complexity and diversity of cellular states, it is becoming necessary for a cellular engineering toolbox, consisting of molecular tools that allow control over cell states and types. Drawing from a combination of natural discovery and rational engineering, we will discuss our lab's recent work in this area. We will cover RNA, DNA, and cell targeting approaches, including the novel CRISPR effector, Cas7-11, that can be used to target transcripts in mammalian cells for degradation, with reduced toxicity; a new genome insertion system, PASTE, that enables efficient, programmable insertion of large DNA segments into the genome without limitations of previous genome editing approaches; and a new approach for control of cell states, RADARS, that can sense and react to transcript levels in cells. These technologies form the basis or new approaches to manipulate and understand cellular states, with implications in basic biology, diagnostics, and therapeutics.
Locked Interactive transcript
More Videos From This Event
See all videos
April 2023
|
Conference Video
4.4.23-Health-Love
J. Christopher Love
Associate Member, Broad Institute
Associate Member, Ragon Institute of MGH, MIT and Harvard
Raymond A. (1921) and Helen E. St. Laurent Professor of Chemical Engineering, Koch Institute for Integrative Cancer Research
April 2023
|
Conference Video
4.4.23-Health-Roche
Ellen Roche
Latham Family Career Development Professor, MIT Department of Mechanical Engineering
April 2023
|
Conference Video
4.4.23-Health-Shalek
Alex Shalek
Pfizer-Laubach Career Development Associate Professor at MIT
Associate Professor of Chemistry, MIT Department of Chemistry
April 2023
|
Conference Video
4.4.23-Health-Blainey
Paul Blainey
Associate Professor of Biological Engineering, MIT Biological Engineering
April 2023
|
Conference Video
4.4.23-Health-Weiss
Ron Weiss
Professor, Biological Engineering
Director, MIT Synthetic Biology Center
April 2023
|
Conference Video
4.4.23-Health-Lieberman
Tami Lieberman
Assistant Professor of Institute for Medical Engineering and Science, Assistant Professor of Civil and Environmental Engineering, MIT Civil and Environmental Engineering
April 2023
|
Conference Video
4.4.23-Health-Kellis
Manolis Kellis
Professor, Computer Science
Head, MIT Computational Biology Group
Associate Member, Broad Institute of MIT and Harvard
Principal Investigator, Computer Science and Artificial Intelligence Lab, MIT Department of Computer Science
April 2023
|
Conference Video
4.4.23-Health-Tadesse
Loza Tadesse
Brit (1961) & Alex (1949) d’Arbeloff Career Development Professor in Mechanical Engineering, MIT Department of Mechanical Engineering
April 2023
|
Conference Video
4.4.23-Health-DxLab
Ho-Jun Suk
Co-Founder & CEO, DxLab
April 2023
|
Conference Video
4.4.23-Health-Ketryx
Erez Kaminski
Founder and CEO, Ketryx Corporation
April 2023
|
Conference Video
4.4.23-Health-Vivtex
Maureen Deehan
Chief Executive Officer, Vivtex
April 2023
|
Conference Video
4.4.23-Health-Tiba-Biotech
Jasdave S. Chahal
Co-Founder and Chief Scientist, Tiba Biotech
April 2023
|
Conference Video
4.4.23-Health-Stratagen-Bio
Greg Ekchian
Co - founder and CEO, Stratagen Bio
April 2023
|
Conference Video
4.4.23-Health-4M-Therapeutics
Benjamin C. Williams
VP of Corporate Development & Co-Founder , 4M Therapeutics
April 2023
|
Conference Video
4.4.23-Health-Decoy-Therapeutics
Rick Pierce
CEO, Decoy Therapeutics
April 2023
|
Conference Video
4.4.23-Health-Replay-Holdings
Matt Mulvey
SVP and Chief Technology Officer, Replay Holdings
April 2023
|
Conference Video
4.4.23-Health-Sunflower-Therapeutics
Laura Crowell
Director of R&D, Sunflower Therapeutics